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INTRODUCTION
Many investigators have described comparisons of 
contrast media with different iodine concentrations in the 
enhancement of multiple organs and vessels on CT scans 
with contrast media of various iodine concentrations (1-7). 
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cortex-outer medulla between 250 mg iodine/mL and 300 mg iodine/mL (p < 0.05). The artifact was more severe with a 
medium of 370 mg iodine/mL than with 250 mg iodine/mL by all grading methods (p < 0.05).
Conclusion: The 300 mg iodine/mL is considered to be the most appropriate iodine concentration in an aspect of the 
enhancement and artifact on a kidney MDCT scan.
Index terms: Kidney; CT; Contrast media; Iodine concentration
Received March 17, 2011; accepted after revision May 6, 2011.
Corresponding author: Seung Hyup Kim, MD, Department of 
Radiology, Seoul National University College of Medicine, 101 
Daehak-ro, Jongno-gu, Seoul 110-744, Korea. 
• Tel: (822) 2072-3321 • Fax: (822) 743-6385
• E-mail: kimsh@radcom.snu.ac.kr
This is an Open Access article distributed under the terms of 
the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0) which permits 
unrestricted non-commercial use, distribution, and reproduction in 
any medium, provided the original work is properly cited. 
Original Article
http://dx.doi.org/10.3348/kjr.2011.12.6.714
pISSN 1229-6929 · eISSN 2005-8330
Korean J Radiol 2011;12(6):714-721
However, to the best of our knowledge, there have been no 
reports of descriptions of renal parenchymal enhancement 
in previous studies. There is however a study about the 
parenchymal enhancement according to contrast media with 
different doses on MR renography (8). Contrary to other 
solid organs, the kidney excretes waste products, including 
contrast media, via the cortex, medulla, and pelvocalyceal 
system. For the kidney, there are characteristic enhancing 
techniques such as the use of the corticomedullary phase 
and the excretory phase for CT imaging. Therefore, results 
from studies with other solid organs cannot be directly 
applied to the kidney. In addition, most previous reports did 
not perform studies in the same patient (3-7, 9), and only a 
few reports have described CT imaging in the same patient 
(10-12). Considering radiation and contrast media exposure, Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 715
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an intra-individual comparison study has many limitations. 
In particular, CT enhancement with contrast media depends 
on various interacting factors such as the nature, volume 
and concentration of the contrast media, the injection 
technique, tissue characteristics, and patient characteristics 
such as sex, age, weight, height, cardiovascular status 
and renal function (2, 3, 13-16). Therefore, an appropriate 
correction of patient characteristics is important for 
a successful comparison study of different iodine 
concentrations of contrast media. A study with an animal 
model is considered to be an appropriate solution in these 
studies.
The renal streak artifact from the characteristic structure 
of the kidney can interfere with the interpretation of CT 
images. The artifact was evaluated according to osmolarity 
degrees of the contrast media with grading systems used 
in a previous study (17). Coincidentally, the artifact is also 
thought to be influenced by the iodine concentration of the 
contrast media.
Therefore, it is important to find an appropriate iodine 
concentration for the contrast media, while keeping 
a balance between the degree of renal parenchymal 
enhancement and the severity of the renal streak artifact 
on multidectector CT (MDCT). We compared the degree of 
renal parenchymal enhancement and the severity of the 
renal streak artifact on MDCT at three different iodine 
concentrations--250, 300, and 370 mg iodine/mL--in the 
contrast media.
MATERIALS AND METHODS
The protocol for the current investigation was approved 
by the Institutional Animal Care and Use Committee of 
the Clinical Research Institute, Seoul National University 
Hospital. Fifteen New Zealand White rabbits (weight range, 
2.8-3.3 kg) were evaluated with contrast-enhanced dynamic 
MDCT using the three concentrations of CT contrast media. 
The rabbits were intramuscularly injected with a mixture 
of tiletamine/zolazepam (Zoletil 50, Virbac Laboratories, 
Carros, France) and xylazine (Rompun, Mobay, Shawnee, KS) 
for sedation. A 22 G intravenous catheter was inserted via a 
marginal ear vein for the infusion of contrast media. 
Each rabbit (n = 15) underwent three CT examinations at 
one-week intervals on a 16-row MDCT scanner (Somatom 
Sensation 16; Siemens Medical Solutions, Malvern, PA) using 
contrast media at three different iodine concentrations. 
We did not control feeding and hydration of the rabbits 
before and after the CT examinations. Contrast media at a 
concentration of 250 mg iodine/mL was used in the first 
week, while contrast media of 300 mg iodine/mL and 370 
mg iodine/mL were used in week 2 and 3, respectively. 
CT scans consisted of a pre-contrast phase and five post-
contrast phases. The first post-contrast scan started 5 
seconds after the attenuation value reached 100 Hounsfield 
units (HUs) in the thoracic aorta using the bolus tracking 
technique. After a 15-second delay, 35-second delay, 
65-second delay, and 115-second delay, additional scans 
were performed. A total of 2 mL/kg of body weight of 
nonionic contrast media (nonionic monomeric iodine 
contrast media, Iopamidol; Pamiray 250, 300, and 370; 
Dongkook Pharmaceutical, Seoul, Korea) was administered 
with a power injector (Envision CT; Medrad, Indianola, PA) 
at a rate of 0.3 mL/sec. Total iodine loads were respectively 
1.5-1.75 g (250 mg iodine/mL), 1.8-2.1 g (300 mg iodine/
mL), and 2.22-2.59 g (370 mg iodine/mL), respectively. 
Scanning parameters were as follows: 0.75 x 16 mm 
detector, 5 mm slice thickness, 5 mm interval, rotation time 
of 0.5 seconds, reconstruction interval of 1 mm, X-ray tube 
voltage of 120 kVp, and an effective tube current of 160 
mAs.
Image Analysis
CT scans of 30 kidneys in 15 rabbits were evaluated 
based on the consensus of two experienced genitourinary 
radiologists using a picture archiving and communications 
system (PACS) workstation (Marotech, Seoul, Korea). 
We considered the right and left kidneys in one rabbit 
separately in the image analysis. We compared the 
attenuation values, the attenuation differences, and the 
severity of the renal streak artifact with contrast media 
at three different iodine concentrations. The attenuation 
values were measured in the aorta, cortex, outer medulla, 
inner medulla and pelvis using the mean value of the 
HUs of all the pixels in a region of interest (ROI) circle. 
The ROI circles were located in the aorta and each sub-
renal structure (cortex, outer medulla, inner medulla and 
pelvis) with the largest diameter and no extension into the 
adjacent structures (Fig. 1). The attenuation differences were 
calculated for the cortex, outer medulla, inner medulla, 
and pelvis (cortex-outer, medulla, outer-inner medulla and 
medulla-pelvis). The renal streak artifact was defined as 
the interference due to concentrated contrast media and 
degradation of the CT image with beam hardening. The 
window width and level were used to determine the degree Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 716
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of severity of the renal streak artifact. Two investigators 
separately controlled the window width and level to acquire 
an image with the most appropriate contrast with minimal 
renal streak artifact for interpretation of the CT images on 
the PACS workstation. The differences between the base 
value (width: 300, level: 35) and the controlled value in 
the window width and level were defined as the degree of 
the renal streak artifact. The differences were calculated 
by subtracting the base value from the controlled value. 
We considered that an increase in the difference of the 
window width and level, which particularly means a wider 
window width and higher window level, indicates increased 
severity of the artifact. In addition, three grading methods 
for determining the degree of severity of the renal streak 
artifact were performed by two investigators in consensus. 
For the first method, each CT image was assigned a score 
of 0 or 1. A score of 0 indicated no artifact and a score of 
1 indicated the presence of artifact. The sum of scores for 
each iodine concentration (250, 300 and 370 mg iodine/
mL) for each rabbit (n = 15) was considered the degree 
of severity of the artifact. For the second method, each 
CT image was assigned a score of 1, 2 or 3. A score of 1 
indicated no interference in CT interpretation. A score of 2 
indicated only interference due to degradation of the renal 
structure, including the detection of concentrated contrast 
media. A score of 3 indicated the conditions required for a 
score of 2 as well as interference due to image degradation 
of structures around the presence of contrast media. For 
the third grading method, scores from 1 to 3 were assigned 
to the CT images in which different iodine concentrations 
were used. A score of 1 indicated the most severe degree 
of artifact. A score of 2 indicated a moderate degree of 
severity and a score of 3 indicated the least degree of 
severity. Sums were determined as described above for the 
first grading method.
Statistical Analysis
We analyzed the attenuation values, the attenuation 
differences and the degree of severity of the renal streak 
artifact according to the CT scan phase and iodine 
concentration of the contrast media in a mixed model using 
the SAS software (version 9.1; SAS Institute, Cary, NC). A 
multiple comparison study was performed with Bonferroni 
correction. For comparison of the degree of severity of 
the renal streak artifact according to the three grading 
methods, the Wilcoxon matched-pairs signed rank test was 
used with Bonferroni correction. A p value less than 0.05 
indicated statistical significance.
RESULTS
There were significant differences in the attenuation 
values for the aorta and cortex with contrast media at the 
three iodine concentrations (p < 0.05). Also, there were 
significant differences between the 250 mg iodine/mL and 
300 mg iodine/mL media (p < 0.01), and between the 250 
mg iodine/mL and 370 mg iodine/mL media (p < 0.05) with 
respect to attenuation values of the aorta. The attenuation 
values of the cortex only showed a significant difference 
between the 250 mg iodine/mL and 370 mg iodine/mL 
Fig. 1. Axial contrast enhanced CT images show five region-of-interest circles at 5-second delay (A) and 115-second delay (B) for 
370 mg iodine/mL. Attenuation values were measured using region-of-interest circles. Region-of-interest circles were located in cortex, outer 
medulla, inner medulla, pelvis and aorta as depicted on PACS workstation.
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media (p < 0.05). CT imaging with 300 mg iodine/mL 
showed no significant difference in enhancement degree 
compared to the 370 mg iodine/mL concentration in all 
phases and all sub-renal structures (p > 0.05). There was no 
significant difference in the attenuation values of the outer 
medulla, inner medulla, and pelvis (p > 0.05) (Table 1). 
There was only a significant difference between the 
250 mg iodine/mL and 300 mg iodine/mL media for the 
attenuation difference of the cortex-outer medulla (p 
< 0.05). CT imaging with 300 mg iodine/mL showed no 
significant difference for the attenuation differences among 
the sub-renal structures compared to the 370 mg iodine/mL 
concentration in all phases (p > 0.05). Other attenuation 
differences, including those between the outer-inner 
medulla and inner medulla-pelvis, were not significantly 
different (Table 2). 
A comparison study of the degree of severity of the renal 
streak artifact as determined by the window width and level 
did not reveal a significant difference (p > 0.05) (Table 3). 
However, according to all grading methods, CT images with 
the 370 mg iodine/mL media showed a renal streak artifact 
with a higher degree of severity than CT images with 250 
mg iodine/mL media (p < 0.05). The artifact with 300 mg 
iodine/mL media showed a higher degree of severity than 
that with the 250 mg iodine/mL media only by the third 
grading method (p < 0.05). None of the grading methods 
showed a significant difference between the 300 mg iodine/
mL and 370 mg iodine/mL media (p > 0.05) (Table 4) (Fig. 
2A-C).
DISCUSSION
Many studies concluded that the use of a higher iodine 
concentration results in greater enhancement on CT images 
(4, 10, 18-22). However, Behrendt et al. (11) presented 
a study in which contrast media with a lower iodine 
concentration resulted in better contrast enhancement than 
a higher iodine concentration (370 mg iodine/mL versus 
300 mg iodine/mL) for equivalent iodine load and delivery 
rate as seen in the early phase of chest MDCT scans. These 
investigators suggested that the viscosity of the contrast 
media plays an important role in contrast enhancement. 
A fluid with a lower viscosity can be injected at a lower 
pressure and may be distributed more easily and more 
evenly in the vessels. The investigators further explained 
that contrast media with a lower iodine concentration 
and the advantage of lower viscosity results in greater 
contrast enhancement in the early phase. Sandstede et 
al. (6) described that the use of contrast media of a high 
iodine concentration (370 mg iodine/mL versus 240 mg 
iodine/mL and 300 mg iodine/mL) showed higher contrast 
enhancement on arterial phase MDCT images with a constant 
Table 3. Differences between Controlled Values and Base Values in Window Width and Level, According to Phase and 
Iodine Concentration for Two Observers
250
b 300
b 370
b
Width Level Width Level Width Level
Observer 1
Phase 1 - Base
a 124.4 ± 61.7 30.7 ± 24 91.7 ± 63.6 16.2 ± 11.4 135.9 ± 73.8 23.9 ± 19
Phase 2 - Base
a 133.1 ± 66.7 27.5 ± 13.9 132 ± 69.6 18.4 ± 16 197.9 ± 153.8 36.2 ± 28.6
Phase 3 - Base
a 278.8 ± 107.8 91.1 ± 34.1 280.4 ± 126.9 63.7 ± 34.8 305.3 ± 187.9 75.9 ± 65.9
Phase 4 - Base
a 366.5 ± 141.6 107.7 ± 47.9 408 ± 199.7 102.5 ± 78.8 408.4 ± 247.7 99.7 ± 60.3
Phase 5 - Base
a 324 ± 123.6 87.4 ± 41.1 355.9 ± 198.1 78.7 ± 70.5 343.3 ± 237.1 50.1 ± 31.8
Observer 2
Phase 1 - Base
a 128.4 ± 59.8 7.6 ± 9.7 106.7 ± 65.5 17.5 ± 18 116.5 ± 92.9 17.2 ± 19.9
Phase 2 - Base
a 104.4 ± 60.7 12.4 ± 10.5 148.8 ± 79.6 30.1 ± 25.7 177.9 ± 171.5 36 ± 47.3
Phase 3 - Base
a 274.1 ± 98.1 40.9 ± 26.4 293.9 ± 131.9 56.2 ± 30.1 299.3 ± 263.1 71 ± 54.9
Phase 4 - Base
a 348.3 ± 100.8 68.7 ± 39.8 396.4 ± 191.5 69.1 ± 58.6 387.7 ± 249.1 91.1 ± 59.9
Phase 5 - Base
a 300.8 ± 114.9 61.1 ± 27.5 322.5 ± 207.1 69.7 ± 44.3 270.1 ± 204.2 52.1 ± 40.5
Note.— Values represent means ± standard deviation for window width and level. No observer showed statistically significant 
difference of subtracted values (controlled value-base value) in window width and level among contrast media for three different 
iodine concentrations (p > 0.05).
aBase values subtracted from controlled values in window width and level on each phase. 
bIodine concentrations in contrast media 
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iodine load and injection rate. This result was discordant 
with the findings of Behrendt et al. (11). However, there 
are no significant effects of different iodine concentrations 
on delay phase images (6, 11). In most studies of solid 
organs, a higher iodine concentration results in higher CT 
enhancement only on early phase images (3, 6, 11). 
In our study, the use of 370 mg iodine/mL contrast 
media provided higher enhancement than the 250 mg 
iodine/mL contrast media for the cortex in all phases (p 
< 0.05). However, there were no significant differences in 
the enhancement degree in each sub-renal structure or 
attenuation among the sub-renal structures between the 
300 mg iodine/mL and 370 mg iodine/mL concentrations in 
all phases. The attenuation values of the medulla and pelvis 
were not significantly different according to the iodine 
concentrations employed in all phases, including the early 
phase. This result may represent a unique characteristic of 
kidney where contrast media travels from the cortex to the 
pelvis. Two explanatory factors for this result are: 1) the 
contrast media does not yet reach the medulla and pelvis 
on early phase CT scans and consequently, the attenuation 
values do not show significant differences in the medulla 
and pelvis; 2) although only a small amount of the contrast 
media arrives in the medulla and pelvis on early phases, 
it is too difficult to detect a difference in enhancement 
among the sub-renal structures on CT scans. Contrary to 
the findings for the medulla and pelvis, the cortex had a 
definite early phase on CT images. Therefore, even though 
the kidney has a characteristic structure as an excretory 
organ, the degree of enhancement had a similar pattern to 
other organs. 
The beam hardening streak artifact arises from uneven 
absorption of the energy produced by the X-ray beam. Lower 
energy components of the polychromatic X-ray beam are 
preferentially absorbed within materials of high attenuation, 
such as concentrated iodinated contrast media or a surgical 
prosthesis. This beam hardening phenomenon contributes 
to the underestimation of attenuation coefficients and 
misinformation with regards to the CT reconstruction 
algorithms (17, 23). The pelvocalyceal system in the kidney 
increases the streak artifact due to the beam hardening 
phenomenon with concentrated iodinated contrast media in 
urine. 
Sussman et al. (17) have described that a contrast 
media of low osmolarity results in a higher incidence in 
the renal streak artifact than a high osmolar agent. These 
investigators explained that a low osmolar contrast media 
with less osmotic diuresis results in a higher concentration 
Table 4. Three Grading Methods for Determining Degree of Severity of Renal Streak Artifact
Rabbit
1st grading  2nd grading 3rd grading
250
a,d 300
c,d 370
a,c,d 250
a,d 300
c,d 370
a,c,d 250
a,b,d 300
b,c,d 370
a,c,d
1 3 4 4 11 12 12 1 2 3
2 3 4 4 9 11 11 1 3 3
3 3 5 5 11 14 13 1 2 3
4 3 4 3 10 12 9 2 3 1
5 5 5 5 12 13 13 1 3 3
6 4 4 4 12 13 12 1 3 2
7 3 3 4 8 9 12 1 2 3
8 3 5 5 9 14 13 1 3 2
9 3 3 3 9 10 9 1 3 2
10 5 4 5 13 12 14 2 1 3
11 4 4 5 12 11 15 1 2 3
12 3 4 5 10 12 14 1 2 3
13 5 4 5 12 10 13 2 1 3
14 3 3 3 10 10 11 1 1 3
15 3 4 5 10 12 14 1 2 3
Note.— Values are scored by each grading method.
aAccording to all grading methods, scores of 370 mg iodine/of mL contrast media is significantly higher for 250 mg iodine/mL (p 
< 0.05). 
bAccording to 3rd grading method, scores of 300 mg iodine/mL of contrast media is significantly higher than for 250 mg 
iodine/mL (p < 0.05). 
cRegardless of three grading methods, there is no significant difference between 300 mg iodine/mL and 370 
mg iodine/mL media (p > 0.05). 
dIodine concentrations in contrast media expressed as mg iodine/mL.Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 720
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of urinary iodine. Low osmolar contrast media is widely used 
in CT examinations due to a lower incidence of contrast-
induced nephropathy (19, 24). In our study, low osmolar 
contrast media was also used. Sussman et al. (17) evaluated 
the degree of severity for the renal streak artifact using a 
grading system in which observers characterized images 
with no artifact, minimal artifact, and marked artifact. In 
our study, a new measurement method using the window 
width and level as determined on the PACS workstation 
was evaluated. The method did not show a statistically 
significant difference according to contrast media of 
different iodine concentrations because of limitations with 
the grading method due to deficient control and inter-
observer variance on images with appropriate contrast. 
However, there was a tendency for observers to interpret 
images with a wider window width on CT scans with a 
higher iodine concentration (Table 3). In contrast, we also 
used three grading systems that could easily discern the 
degree of severity of the artifact according to the three 
iodine concentrations, as seen on the PACS workstation.
This current study has limitations related to the use of an 
animal model. However, the evaluation of the characteristic 
renal CT enhancement provides details that will be useful 
for future studies. In this study, the injection volume of 
contrast media could not be controlled beyond the unit 
level because of the use of the power injector like that used 
in a clinical setting. We performed the study with using a 
constant injection protocol based on a renal CT protocol in 
use at our institute. Therefore, various protocols examining 
factors such as injection rate, injection volume or constant 
iodine load will be necessary in a future study.
In conclusion, CT imaging with contrast media at 
a concentration of 370 mg iodine/mL showed better 
enhancement for the renal cortex than at 250 mg iodine/
A
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C
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Pre
Pre
1
1
1
2
2
2
3
3
3
4
4
4
5
5
5
Fig. 2.  Axial contrast enhanced CT images in rabbit show various CT enhancement patterns according to six phases and use of contrast media 
with three iodine concentrations. CT images show prominent differences of enhancement according to iodine concentration of contrast media 
in renal cortex regardless of phase, with most severe renal steak artifact produced with concentration of 370 mg iodine/mL. Three rows indicate 
iodine concentrations: A. 250 mg iodine/mL, B. 300 mg iodine/mL, C. 370 mg iodine/mL. Six columns indicate each phase as function of time: 
pre (pre-contrast), phase 1 (5-second delay), phase 2 (15-second delay), phase 3 (35-second delay), phase 4 (65-second delay), and phase 5 
(115-second delay). Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 721
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mL and, no significant difference in the attenuation values 
was found compared to 300 mg iodine/mL. The renal streak 
artifact was more severe for contrast media at 370 mg 
iodine/mL contrast than at 250 mg iodine/mL on MDCT 
images. Therefore, the 300 mg iodine/mL was considered to 
be the most appropriate iodine concentration in an aspect 
of the enhancement and artifact on the kidney MDCT scan.
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